Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Abroad (travel likely)RecruitingPHASE3

Conditions

Clear Cell Renal Cell Carcinoma · Renal Cell Carcinoma (RCC) · Stage II Renal Pelvis Cancer AJCC v8 · Stage III Renal Pelvis Cancer AJCC v8

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Cancer Center at Saint Joseph's, Phoenix, Arizona, United States

    Contact: Study coordinator (Site Public Contact) · ResearchInstituteInquiries@CommonSpirit.org · 720-874-1881
    Contact: Principal Investigator (Shahzad Siddique)
  • Banner University Medical Center - Tucson, Tucson, Arizona, United States

    Contact: Study coordinator (Site Public Contact) · UACC-IIT@uacc.arizona.edu
    Contact: Principal Investigator (Edward P. Gelmann)
  • University of Arizona Cancer Center-North Campus, Tucson, Arizona, United States

    Contact: Study coordinator (Site Public Contact) · UACC-IIT@uacc.arizona.edu
    Contact: Principal Investigator (Edward P. Gelmann)
  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro, Arkansas, United States

    Contact: Study coordinator (Site Public Contact) · Emily.Carvell@bmhcc.org · 870-936-7066
    Contact: Principal Investigator (Osarenren Ogbeide)
  • University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

    Contact: Study coordinator (Site Public Contact) · 501-686-8274
    Contact: Principal Investigator (Anuradha Kunthur)
  • Sutter Auburn Faith Hospital, Auburn, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Uma Suryadevara)
  • Tower Cancer Research Foundation, Beverly Hills, California, United States

    Contact: Study coordinator (Site Public Contact) · towercancerresearch@toweroncology.com
    Contact: Principal Investigator (Edwin M. Posadas)
  • City of Hope Comprehensive Cancer Center, Duarte, California, United States

    Contact: Study coordinator (Site Public Contact) · becomingapatient@coh.org · 800-826-4673
    Contact: Principal Investigator (Wesley Yip)
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine, California, United States

    Contact: Study coordinator (Site Public Contact) · ucstudy@uci.edu · 877-827-8839
    Contact: Principal Investigator (Nataliya Mar)
  • City of Hope at Irvine Lennar, Irvine, California, United States

    Contact: Study coordinator (Site Public Contact) · 877-467-3411
    Contact: Principal Investigator (Wesley Yip)
  • UC San Diego Moores Cancer Center, La Jolla, California, United States

    Contact: Study coordinator (Site Public Contact) · cancercto@ucsd.edu · 858-822-5354
    Contact: Principal Investigator (Rana R. McKay)
  • City of Hope Antelope Valley, Lancaster, California, United States

    Contact: Study coordinator (Site Public Contact) · becomingapatient@coh.org · 800-826-4673
    Contact: Principal Investigator (Wesley Yip)
  • Los Angeles General Medical Center, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · uscnorrisinfo@med.usc.edu · 323-865-0451
    Contact: Principal Investigator (Varsha Tulpule)
  • USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · 323-865-0451
    Contact: Principal Investigator (Varsha Tulpule)
  • Cedars-Sinai Medical Center, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · Cancer.trial.info@cshs.org · 310-423-2133
    Contact: Principal Investigator (Edwin M. Posadas)
  • Memorial Medical Center, Modesto, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Uma Suryadevara)
  • USC Norris Oncology/Hematology-Newport Beach, Newport Beach, California, United States

    Contact: Study coordinator (Site Public Contact) · 323-865-0451
    Contact: Principal Investigator (Varsha Tulpule)
  • UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States

    Contact: Study coordinator (Site Public Contact) · ucstudy@uci.edu · 877-827-8839
    Contact: Principal Investigator (Nataliya Mar)
  • Palo Alto Medical Foundation Health Care, Palo Alto, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Uma Suryadevara)
  • Sutter Roseville Medical Center, Roseville, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Uma Suryadevara)
  • Sutter Medical Center Sacramento, Sacramento, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Uma Suryadevara)
  • University of California Davis Comprehensive Cancer Center, Sacramento, California, United States

    Contact: Study coordinator (Site Public Contact) · 916-734-3089
    Contact: Principal Investigator (Shuchi Gulati)
  • UC San Diego Medical Center - Hillcrest, San Diego, California, United States

    Contact: Study coordinator (Site Public Contact) · rhabbaba@health.ucsd.edu
    Contact: Principal Investigator (Rana R. McKay)
  • California Pacific Medical Center-Pacific Campus, San Francisco, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Uma Suryadevara)
  • Mills Health Center, San Mateo, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Uma Suryadevara)
  • Palo Alto Medical Foundation-Santa Cruz, Santa Cruz, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Uma Suryadevara)
  • Palo Alto Medical Foundation-Sunnyvale, Sunnyvale, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Uma Suryadevara)
  • City of Hope South Bay, Torrance, California, United States

    Contact: Study coordinator (Site Public Contact) · 877-467-3411
    Contact: Principal Investigator (Wesley Yip)
  • Torrance Memorial Physician Network - Cancer Care, Torrance, California, United States

    Contact: Study coordinator (Site Public Contact) · courtney.steeneken@tmphysicians.com · 310-750-3300
    Contact: Principal Investigator (Edwin M. Posadas)
  • City of Hope Upland, Upland, California, United States

    Contact: Study coordinator (Site Public Contact) · becomingapatient@coh.org · 800-826-4673
    Contact: Principal Investigator (Wesley Yip)
  • Sutter Solano Medical Center/Cancer Center, Vallejo, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Uma Suryadevara)
  • UCHealth University of Colorado Hospital, Aurora, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 720-848-0650
    Contact: Principal Investigator (Corbin Eule)
  • UCHealth Memorial Hospital Central, Colorado Springs, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 719-365-2406
    Contact: Principal Investigator (Corbin Eule)
  • Memorial Hospital North, Colorado Springs, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 719-364-6700
    Contact: Principal Investigator (Corbin Eule)
  • UCHealth - Cherry Creek, Denver, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · protocols@AllianceNCTN.org · 773-702-9171
    Contact: Principal Investigator (Corbin Eule)
  • Poudre Valley Hospital, Fort Collins, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 970-297-6150
    Contact: Principal Investigator (Corbin Eule)
  • Cancer Care and Hematology-Fort Collins, Fort Collins, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · protocols@AllianceNCTN.org · 773-702-9171
    Contact: Principal Investigator (Corbin Eule)
  • UCHealth Greeley Hospital, Greeley, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · protocols@AllianceNCTN.org · 773-702-9171
    Contact: Principal Investigator (Corbin Eule)
  • UCHealth Highlands Ranch Hospital, Highlands Ranch, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 720-848-0650
    Contact: Principal Investigator (Corbin Eule)
  • UCHealth Lone Tree Health Center, Lone Tree, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · protocols@AllianceNCTN.org · 773-702-9171
    Contact: Principal Investigator (Corbin Eule)
  • Medical Center of the Rockies, Loveland, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 970-203-7083
    Contact: Principal Investigator (Corbin Eule)
  • Hartford HealthCare - Avon, Avon, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · 860-972-4700
    Contact: Principal Investigator (Michael Sun)
  • Hartford HealthCare - Saint Vincent's Medical Center, Bridgeport, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · 860-972-4700
    Contact: Principal Investigator (Michael Sun)
  • Smilow Cancer Hospital-Derby Care Center, Derby, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (David A. Braun)
  • Hartford Healthcare - Fairfield, Fairfield, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · CancerResearchSupport@hhchealth.org · 860-972-4700
    Contact: Principal Investigator (Michael Sun)
  • Smilow Cancer Hospital Care Center-Fairfield, Fairfield, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (David A. Braun)
  • Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury, Connecticut, United States

  • Smilow Cancer Hospital Care Center at Greenwich, Greenwich, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (David A. Braun)
  • Smilow Cancer Hospital Care Center - Guilford, Guilford, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (David A. Braun)
  • Hartford Hospital, Hartford, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · 860-545-5363
    Contact: Principal Investigator (Michael Sun)
  • Smilow Cancer Hospital Care Center at Saint Francis, Hartford, Connecticut, United States

  • Hartford HealthCare - Manchester, Manchester, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · 860-972-4700
    Contact: Principal Investigator (Michael Sun)
  • Midstate Medical Center, Meriden, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · 866-662-5678
    Contact: Principal Investigator (Michael Sun)
  • The Hospital of Central Connecticut, New Britain, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · 860-224-5660
    Contact: Principal Investigator (Michael Sun)
  • Yale University, New Haven, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (David A. Braun)
  • Yale-New Haven Hospital North Haven Medical Center, North Haven, Connecticut, United States

  • Smilow Cancer Hospital Care Center at Long Ridge, Stamford, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (David A. Braun)
  • Stamford Hospital/Bennett Cancer Center, Stamford, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · 203-323-8944
    Contact: Principal Investigator (Anthony P. Gulati)
  • Smilow Cancer Hospital-Torrington Care Center, Torrington, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (David A. Braun)
  • Smilow Cancer Hospital Care Center-Trumbull, Trumbull, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (David A. Braun)
  • Smilow Cancer Hospital-Waterbury Care Center, Waterbury, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (David A. Braun)
  • Smilow Cancer Hospital Care Center - Waterford, Waterford, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (David A. Braun)
  • Beebe South Coastal Health Campus, Millville, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · research@beebehealthcare.org · 302-291-6730
    Contact: Principal Investigator (Gregory A. Masters)
  • Helen F Graham Cancer Center, Newark, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · lbarone@christianacare.org · 302-623-4450
    Contact: Principal Investigator (Gregory A. Masters)
  • Medical Oncology Hematology Consultants PA, Newark, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · lbarone@christianacare.org · 302-623-4450
    Contact: Principal Investigator (Gregory A. Masters)
  • Beebe Health Campus, Rehoboth Beach, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · research@beebehealthcare.org · 302-291-6730
    Contact: Principal Investigator (Gregory A. Masters)
  • MedStar Washington Hospital Center, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (Site Public Contact) · 202-877-8839
    Contact: Principal Investigator (Suthee Rapisuwon)
  • George Washington University Medical Center, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (Site Public Contact) · 202-741-2210
    Contact: Principal Investigator (Karan Jatwani)
  • UF Health Cancer Institute - Gainesville, Gainesville, Florida, United States

    Contact: Study coordinator (Site Public Contact) · cancer-center@ufl.edu · 352-273-8010
    Contact: Principal Investigator (Daniel V. Araujo)
  • Miami Cancer Institute, Miami, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 786-596-2000
    Contact: Principal Investigator (Rohan Garje)
  • Grady Health System, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · 404-778-1868
    Contact: Principal Investigator (Viraj Master)
  • Emory University Hospital Midtown, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · 888-946-7447
    Contact: Principal Investigator (Viraj Master)
  • Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · 404-778-1868
    Contact: Principal Investigator (Viraj Master)
  • Emory Saint Joseph's Hospital, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · 404-851-7115
    Contact: Principal Investigator (Viraj Master)
  • Emory Johns Creek Hospital, Johns Creek, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · m.lisa.hwang@emory.edu · 404-778-5714
    Contact: Principal Investigator (Viraj Master)
  • Saint Luke's Cancer Institute - Boise, Boise, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · eslinget@slhs.org · 208-381-2774
    Contact: Principal Investigator (Alison K. Conlin)
  • Kootenai Health - Coeur d'Alene, Coeur d'Alene, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Saint Luke's Cancer Institute - Fruitland, Fruitland, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · eslinget@slhs.org · 208-381-2774
    Contact: Principal Investigator (Alison K. Conlin)
  • Saint Luke's Cancer Institute - Meridian, Meridian, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · eslinget@slhs.org · 208-381-2774
    Contact: Principal Investigator (Alison K. Conlin)
  • Saint Luke's Cancer Institute - Nampa, Nampa, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · eslinget@slhs.org · 208-381-2774
    Contact: Principal Investigator (Alison K. Conlin)
  • Kootenai Clinic Cancer Services - Post Falls, Post Falls, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Kootenai Clinic Cancer Services - Sandpoint, Sandpoint, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Rush-Copley Medical Center, Aurora, Illinois, United States

  • Advocate Outpatient Center - Aurora, Aurora, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aah.org
    Contact: Principal Investigator (Adam P. Siegel)
  • Advocate Good Shepherd Hospital, Barrington, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 847-842-4847
    Contact: Principal Investigator (Adam P. Siegel)
  • Illinois CancerCare-Bloomington, Bloomington, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Canton, Canton, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • SIH Cancer Institute, Carterville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · clinical.research@sih.net · 618-985-3333
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Carthage, Carthage, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Northwestern University, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancer@northwestern.edu · 312-695-1301
    Contact: Principal Investigator (David VanderWeele)
  • Rush MD Anderson Cancer Center, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Cancer_Studies@rush.edu · 312-226-2371
    Contact: Principal Investigator (Manan Shah)
  • University of Illinois, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 312-355-3046
    Contact: Principal Investigator (Karine Tawagi)
  • Advocate Illinois Masonic Medical Center, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 773-296-5360
    Contact: Principal Investigator (Adam P. Siegel)
  • AMG Crystal Lake - Oncology, Crystal Lake, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · advocateresearch@advocate.com · 630-929-6129
    Contact: Principal Investigator (Adam P. Siegel)
  • Carle at The Riverfront, Danville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@Carle.com · 800-446-5532
    Contact: Principal Investigator (Suparna Mantha)
  • Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Decatur Memorial Hospital, Decatur, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Northwestern Medicine Cancer Center Kishwaukee, DeKalb, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Donald.Smith3@nm.org · 630-352-5360
    Contact: Principal Investigator (David VanderWeele)
  • Illinois CancerCare-Dixon, Dixon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 815-285-7800
    Contact: Principal Investigator (Bryan A. Faller)
  • Advocate Good Samaritan Hospital, Downers Grove, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Barbara.barhamand@advocatehealth.com · 630-275-1270
    Contact: Principal Investigator (Adam P. Siegel)
  • Carle Physician Group-Effingham, Effingham, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Suparna Mantha)
  • Crossroads Cancer Center, Effingham, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Advocate Sherman Hospital, Elgin, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 847-429-2907
    Contact: Principal Investigator (Adam P. Siegel)
  • Elmhurst Memorial Hospital, Elmhurst, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Jrohde@emhc.org · 630-758-5460
    Contact: Principal Investigator (Matthew Siegel)
  • Illinois CancerCare-Eureka, Eureka, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Galesburg, Galesburg, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Northwestern Medicine Cancer Center Delnor, Geneva, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Donald.Smith3@nm.org · 630-352-5360
    Contact: Principal Investigator (David VanderWeele)
  • Northwestern Medicine Glenview Outpatient Center, Glenview, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 312-695-1102
    Contact: Principal Investigator (David VanderWeele)
  • Northwestern Medicine Grayslake Outpatient Center, Grayslake, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 312-695-1102
    Contact: Principal Investigator (David VanderWeele)
  • Advocate South Suburban Hospital, Hazel Crest, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 708-799-9995
    Contact: Principal Investigator (Adam P. Siegel)
  • Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Northwestern Medicine Lake Forest Hospital, Lake Forest, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancertrials@northwestern.edu
    Contact: Principal Investigator (David VanderWeele)
  • AMG Libertyville - Oncology, Libertyville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · advocateresearch@advocatehealth.com · 630-929-6129
    Contact: Principal Investigator (Adam P. Siegel)
  • Condell Memorial Hospital, Libertyville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · advocateresearch@advocatehealth.com · 630-929-6129
    Contact: Principal Investigator (Adam P. Siegel)
  • Illinois CancerCare-Macomb, Macomb, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Suparna Mantha)
  • Trinity Medical Center, Moline, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 309-779-2000
    Contact: Principal Investigator (Suparna Mantha)
  • Edward Hospital/Cancer Center, Naperville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 630-646-6075
    Contact: Principal Investigator (Matthew Siegel)
  • Cancer Care Center of O'Fallon, O'Fallon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Northwestern Medicine Oak Brook, Oak Brook, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · nctnprogram_rhlccc@northwestern.edu
    Contact: Principal Investigator (David VanderWeele)
  • Advocate Christ Medical Center, Oak Lawn, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 800-323-8622
    Contact: Principal Investigator (Adam P. Siegel)
  • Advocate Outpatient Center - Oak Lawn, Oak Lawn, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aah.org
    Contact: Principal Investigator (Adam P. Siegel)
  • Northwestern Medicine Orland Park, Orland Park, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · nctnprogram_rhlccc@northwestern.edu
    Contact: Principal Investigator (David VanderWeele)
  • Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Advocate High Tech Medical Park, Palos Heights, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aah.org
    Contact: Principal Investigator (Adam P. Siegel)
  • Advocate Lutheran General Hospital, Park Ridge, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 847-384-3621
    Contact: Principal Investigator (Adam P. Siegel)
  • Illinois CancerCare-Pekin, Pekin, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Peoria, Peoria, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Peru, Peru, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Edward Hospital/Cancer Center?Plainfield, Plainfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Cancerresearch@edward.org · 630-646-6075
    Contact: Principal Investigator (Matthew Siegel)
  • Illinois CancerCare-Princeton, Princeton, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Memorial Hospital East, Shiloh, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · dschwab@wustl.edu · 314-747-9912
    Contact: Principal Investigator (Melissa A. Reimers)
  • Southern Illinois University School of Medicine, Springfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 217-545-7929
    Contact: Principal Investigator (Bryan A. Faller)
  • Springfield Clinic, Springfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 800-444-7541
    Contact: Principal Investigator (Bryan A. Faller)
  • Springfield Memorial Hospital, Springfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · pallante.beth@mhsil.com · 217-528-7541
    Contact: Principal Investigator (Bryan A. Faller)
  • Carle Cancer Center, Urbana, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Suparna Mantha)
  • Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Donald.Smith3@nm.org · 630-352-5360
    Contact: Principal Investigator (David VanderWeele)
  • Illinois CancerCare - Washington, Washington, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Rush-Copley Healthcare Center, Yorkville, Illinois, United States

  • IU Health West Hospital, Avon, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · iutrials@iu.edu · 317-278-5632
    Contact: Principal Investigator (Jennifer King)
  • IU Health North Hospital, Carmel, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · iutrials@iu.edu · 317-278-5632
    Contact: Principal Investigator (Jennifer King)
  • Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · iutrials@iu.edu · 317-278-5632
    Contact: Principal Investigator (Jennifer King)
  • Sidney and Lois Eskenazi Hospital, Indianapolis, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · iutrials@iu.edu · 317-278-5632
    Contact: Principal Investigator (Jennifer King)
  • Mary Greeley Medical Center, Ames, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-956-4132
    Contact: Principal Investigator (Joseph J. Merchant)
  • McFarland Clinic - Ames, Ames, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · ksoder@mcfarlandclinic.com · 515-239-4734
    Contact: Principal Investigator (Joseph J. Merchant)
  • University of Iowa Healthcare Cancer Services Quad Cities, Bettendorf, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · katherine-daprile@uiowa.edu · 563-355-7733
    Contact: Principal Investigator (Fernando Maciel Barbosa)
  • McFarland Clinic - Boone, Boone, Iowa, United States

  • Mercy Hospital, Cedar Rapids, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 319-365-4673
    Contact: Principal Investigator (Deborah W. Wilbur)
  • Oncology Associates at Mercy Medical Center, Cedar Rapids, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 319-363-2690
    Contact: Principal Investigator (Deborah W. Wilbur)
  • McFarland Clinic - Trinity Cancer Center, Fort Dodge, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-956-4132
    Contact: Principal Investigator (Joseph J. Merchant)
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 800-237-1225
    Contact: Principal Investigator (Fernando Maciel Barbosa)
  • McFarland Clinic - Jefferson, Jefferson, Iowa, United States

  • McFarland Clinic - Marshalltown, Marshalltown, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-956-4132
    Contact: Principal Investigator (Joseph J. Merchant)
  • The James Graham Brown Cancer Center at University of Louisville, Louisville, Kentucky, United States

    Contact: Study coordinator (Site Public Contact) · 502-562-3429
    Contact: Principal Investigator (Rohit Kumar)
  • Baptist Health Louisville, Louisville, Kentucky, United States

    Contact: Study coordinator (Site Public Contact) · Cbcresearch@bhsi.com · 502-897-8592
    Contact: Principal Investigator (Vikas K. Singh)
  • UofL Health Medical Center Northeast, Louisville, Kentucky, United States

    Contact: Study coordinator (Site Public Contact) · ctoinfo@louisville.edu · 502-852-2755
    Contact: Principal Investigator (Rohit Kumar)
  • Ochsner Medical Center Jefferson, New Orleans, Louisiana, United States

    Contact: Study coordinator (Site Public Contact) · Elisemarie.curry@ochsner.org · 504-842-8084
    Contact: Principal Investigator (Brian T. Halbert)
  • Lafayette Family Cancer Center-EMMC, Brewer, Maine, United States

    Contact: Study coordinator (Site Public Contact) · 800-987-3005
    Contact: Principal Investigator (Sarah J. Sinclair)
  • UPMC Western Maryland, Cumberland, Maryland, United States

    Contact: Study coordinator (Site Public Contact) · 240-964-1400
    Contact: Principal Investigator (Leonard J. Appleman)
  • Beverly Hospital, Beverly, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · 978-922-3000
    Contact: Principal Investigator (Brendan Connell)
  • Dana-Farber Cancer Institute, Boston, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · 877-442-3324
    Contact: Principal Investigator (Bradley A. McGregor)
  • Lahey Clinic, Burlington, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · lhmc-cancer-clinical-trials@lahey.org · 781-744-3421
    Contact: Principal Investigator (Brendan Connell)
  • Dana-Farber Cancer Institute at Foxborough, Foxborough, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · 877-338-7425
    Contact: Principal Investigator (Daniel Roberts)
  • Addison Gilbert Hospital, Gloucester, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · 978-283-4000
    Contact: Principal Investigator (Brendan Connell)
  • Dana Farber-Merrimack Valley, Methuen, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · 877-338-7425
    Contact: Principal Investigator (Pedro M. Sanz-Altamira)
  • Dana-Farber/Brigham and Women's Cancer Center at Milford Regional, Milford, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · 877-332-4294
    Contact: Principal Investigator (Daniel E. Fein)
  • Lahey Clinic Peabody, Peabody, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · lhmc-cancer-clinical-trials@lahey.org · 781-744-3421
    Contact: Principal Investigator (Brendan Connell)
  • Dana-Farber/Brigham and Women's Cancer Center at South Shore, South Weymouth, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · 781-624-5000
    Contact: Principal Investigator (James H. Stoeckle)
  • Bronson Battle Creek, Battle Creek, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Houssam Y. Hariri)
  • Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Houssam Y. Hariri)
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Houssam Y. Hariri)
  • OSF Saint Francis Hospital and Medical Group, Escanaba, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · WI_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Anthony J. Jaslowski)
  • Cancer Hematology Centers - Flint, Flint, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · wstrong@ghci.org · 810-762-8038
    Contact: Principal Investigator (Houssam Y. Hariri)
  • Genesee Hematology Oncology PC, Flint, Michigan, United States

  • Genesys Hurley Cancer Institute, Flint, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · wstrong@ghci.org · 810-762-8038
    Contact: Principal Investigator (Houssam Y. Hariri)
  • Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Trinity Health Grand Rapids Hospital, Grand Rapids, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Bronson Methodist Hospital, Kalamazoo, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • West Michigan Cancer Center, Kalamazoo, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • University of Michigan Health - Sparrow Lansing, Lansing, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · harsha.trivedi@umhsparrow.org · 517-364-3712
    Contact: Principal Investigator (Houssam Y. Hariri)
  • Trinity Health Saint Mary Mercy Livonia Hospital, Livonia, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Houssam Y. Hariri)
  • Trinity Health Muskegon Hospital, Muskegon, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Corewell Health Lakeland Hospitals - Niles Hospital, Niles, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Cancer and Hematology Centers of Western Michigan - Norton Shores, Norton Shores, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · connie.szczepanek@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Trinity Health Saint Joseph Mercy Oakland Hospital, Pontiac, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Houssam Y. Hariri)
  • Corewell Health Reed City Hospital, Reed City, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center, Saint Joseph, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Corewell Health Lakeland Hospitals - Saint Joseph Hospital, Saint Joseph, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Munson Medical Center, Traverse City, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • University of Michigan Health - West, Wyoming, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Houssam Y. Hariri)
  • Sanford Joe Lueken Cancer Center, Bemidji, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 218-333-5000
    Contact: Principal Investigator (Daniel Almquist)
  • Essentia Health Saint Joseph's Medical Center, Brainerd, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Minnesota Oncology - Burnsville, Burnsville, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Mercy Hospital, Coon Rapids, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Essentia Health - Deer River Clinic, Deer River, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Essentia Health Cancer Center, Duluth, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Fairview Southdale Hospital, Edina, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Essentia Health Hibbing Clinic, Hibbing, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Minnesota Oncology Hematology PA-Maplewood, Maplewood, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Hennepin County Medical Center, Minneapolis, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Minneapolis VA Medical Center, Minneapolis, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · 612-467-2800
    Contact: Principal Investigator (Nivedita Arora)
  • North Memorial Medical Health Center, Robbinsdale, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · coborncancercenter@centracare.com · 877-229-4907
    Contact: Principal Investigator (Donald J. Jurgens)
  • Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Regions Hospital, Saint Paul, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • United Hospital, Saint Paul, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Essentia Health Sandstone, Sandstone, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Saint Francis Regional Medical Center, Shakopee, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Essentia Health Virginia Clinic, Virginia, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Minnesota Oncology Hematology PA-Woodbury, Woodbury, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus, Mississippi, United States

    Contact: Study coordinator (Site Public Contact) · BCCclintrials@bmhcc.org · 901-226-1366
    Contact: Principal Investigator (Osarenren Ogbeide)
  • Baptist Cancer Center-Grenada, Grenada, Mississippi, United States

    Contact: Study coordinator (Site Public Contact) · BCCclintrials@bmhcc.org · 901-226-1366
    Contact: Principal Investigator (Osarenren Ogbeide)
  • University of Mississippi Medical Center, Jackson, Mississippi, United States

    Contact: Study coordinator (Site Public Contact) · 601-815-6700
    Contact: Principal Investigator (John C. Henegan)
  • Baptist Memorial Hospital and Cancer Center-Union County, New Albany, Mississippi, United States

    Contact: Study coordinator (Site Public Contact) · BCCclintrials@bmhcc.org · 901-226-1366
    Contact: Principal Investigator (Osarenren Ogbeide)
  • Baptist Memorial Hospital and Cancer Center-Oxford, Oxford, Mississippi, United States

    Contact: Study coordinator (Site Public Contact) · BCCclintrials@bmhcc.org · 901-226-1366
    Contact: Principal Investigator (Osarenren Ogbeide)
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven, Mississippi, United States

    Contact: Study coordinator (Site Public Contact) · BCCclintrials@bmhcc.org · 901-226-1366
    Contact: Principal Investigator (Osarenren Ogbeide)
  • Saint Francis Medical Center, Cape Girardeau, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · sfmc@sfmc.net · 573-334-2230
    Contact: Principal Investigator (Bryan A. Faller)
  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Melissa A. Reimers)
  • Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Melissa A. Reimers)
  • Parkland Health Center - Farmington, Farmington, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-996-5569
    Contact: Principal Investigator (Bryan A. Faller)
  • Sainte Genevieve County Memorial Hospital, Sainte Genevieve, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-996-5569
    Contact: Principal Investigator (Bryan A. Faller)
  • Washington University School of Medicine, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Melissa A. Reimers)
  • Mercy Hospital South, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · Danielle.Werle@mercy.net · 314-525-6042
    Contact: Principal Investigator (Jay W. Carlson)
  • Siteman Cancer Center-South County, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Melissa A. Reimers)
  • Missouri Baptist Medical Center, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-996-5569
    Contact: Principal Investigator (Bryan A. Faller)
  • Siteman Cancer Center at Christian Hospital, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Melissa A. Reimers)
  • Mercy Hospital Saint Louis, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-251-7066
    Contact: Principal Investigator (Jay W. Carlson)
  • Missouri Baptist Sullivan Hospital, Sullivan, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-996-5569
    Contact: Principal Investigator (Bryan A. Faller)
  • BJC Outpatient Center at Sunset Hills, Sunset Hills, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-996-5569
    Contact: Principal Investigator (Bryan A. Faller)
  • Community Hospital of Anaconda, Anaconda, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Billings Clinic Cancer Center, Billings, Montana, United States

    Contact: Study coordinator (Site Public Contact) · research@billingsclinic.org · 800-996-2663
    Contact: Principal Investigator (John M. Schallenkamp)
  • Bozeman Health Deaconess Hospital, Bozeman, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Benefis Sletten Cancer Institute, Great Falls, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Logan Health Medical Center, Kalispell, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Community Medical Center, Missoula, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon, New Hampshire, United States

    Contact: Study coordinator (Site Public Contact) · cancer.research.nurse@dartmouth.edu · 800-639-6918
    Contact: Principal Investigator (Jacob B. Reibel)
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Darren R. Feldman)
  • Jefferson Cherry Hill Hospital, Cherry Hill, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · ONCTrialNow@jefferson.edu · 215-600-9151
    Contact: Principal Investigator (Patrick Mille)
  • Hackensack University Medical Center, Hackensack, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 551-996-2897
    Contact: Principal Investigator (Robert S. Alter)
  • The Cancer Institute of New Jersey Hamilton, Hamilton, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 609-631-6946
    Contact: Principal Investigator (Biren Saraiya)
  • Monmouth Medical Center, Long Branch, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · mary.danish@rwjbh.org · 732-923-6564
    Contact: Principal Investigator (Biren Saraiya)
  • Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Darren R. Feldman)
  • Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Darren R. Feldman)
  • Morristown Medical Center, Morristown, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 973-971-5900
    Contact: Principal Investigator (William Rafelson)
  • Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 732-235-7356
    Contact: Principal Investigator (Biren Saraiya)
  • Rutgers New Jersey Medical School, Newark, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 732-235-7356
    Contact: Principal Investigator (Biren Saraiya)
  • Sidney Kimmel Cancer Center Washington Township, Sewell, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · ONCTrialNow@jefferson.edu · 215-600-9151
    Contact: Principal Investigator (Patrick Mille)
  • Robert Wood Johnson University Hospital Somerset, Somerville, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · Siby.Varughese@rwjbh.org · 908-685-2481
    Contact: Principal Investigator (Biren Saraiya)
  • Overlook Hospital, Summit, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 908-522-2043
    Contact: Principal Investigator (William Rafelson)
  • University of New Mexico Cancer Center, Albuquerque, New Mexico, United States

    Contact: Study coordinator (Site Public Contact) · HSC-ClinicalTrialInfo@salud.unm.edu · 505-925-0348
    Contact: Principal Investigator (Amy C. Tarnower)
  • Roswell Park Cancer Institute, Buffalo, New York, United States

    Contact: Study coordinator (Site Public Contact) · askroswell@roswellpark.org · 800-767-9355
    Contact: Principal Investigator (Saby George)
  • Hematology Oncology Associates of CNY at Camillus, Camillus, New York, United States

    Contact: Study coordinator (Site Public Contact) · 315-472-7504
    Contact: Principal Investigator (Steven M. Duffy)
  • Memorial Sloan Kettering Commack, Commack, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Darren R. Feldman)
  • Hematology Oncology Associates of Central New York-East Syracuse, East Syracuse, New York, United States

    Contact: Study coordinator (Site Public Contact) · 315-472-7504
    Contact: Principal Investigator (Steven M. Duffy)
  • Glens Falls Hospital, Glens Falls, New York, United States

    Contact: Study coordinator (Site Public Contact) · 518-926-6700
    Contact: Principal Investigator (John P. Stoutenburg)
  • Memorial Sloan Kettering Westchester, Harrison, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Darren R. Feldman)
  • Northwell Health/Center for Advanced Medicine, Lake Success, New York, United States

    Contact: Study coordinator (Site Public Contact) · 516-734-8896
    Contact: Principal Investigator (Xinhua Zhu)
  • Mount Sinai Chelsea, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · CCTO@mssm.edu · 212-824-7309
    Contact: Principal Investigator (Eric J. Miller)
  • Mount Sinai Hospital, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · CCTO@mssm.edu · 212-824-7309
    Contact: Principal Investigator (Eric J. Miller)
  • Manhattan Eye Ear and Throat Hospital, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-434-4460
    Contact: Principal Investigator (Xinhua Zhu)
  • Memorial Sloan Kettering Cancer Center, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Darren R. Feldman)
  • Lenox Hill Hospital, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · 516-734-8896
    Contact: Principal Investigator (Xinhua Zhu)
  • Montefiore Medical Center-Einstein Campus, The Bronx, New York, United States

    Contact: Study coordinator (Site Public Contact) · eskwak@montefiore.org · 718-379-6866
    Contact: Principal Investigator (Benjamin A. Gartrell)
  • Memorial Sloan Kettering Nassau, Uniondale, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Darren R. Feldman)
  • AdventHealth Infusion Center Asheville, Asheville, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · AMBER.WHEELER@AdventHealth.com · 828-650-8037
    Contact: Principal Investigator (Jennifer L. Heaberlin)
  • Duke Cancer Center Cary, Cary, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · NCTNStudyTeam@dm.duke.edu
    Contact: Principal Investigator (Daniel J. George)
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@med.unc.edu · 877-668-0683
    Contact: Principal Investigator (Tracy L. Rose)
  • AdventHealth Infusion Center Haywood, Clyde, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · AMBER.WHEELER@AdventHealth.com · 828-650-8037
    Contact: Principal Investigator (Jennifer L. Heaberlin)
  • Duke University Medical Center, Durham, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 888-275-3853
    Contact: Principal Investigator (Daniel J. George)
  • Duke Cancer Center Southpoint, Durham, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · NCTNStudyTeam@dm.duke.edu
    Contact: Principal Investigator (Daniel J. George)
  • AdventHealth Hendersonville, Hendersonville, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · AMBER.WHEELER@AdventHealth.com · 828-650-8037
    Contact: Principal Investigator (Jennifer L. Heaberlin)
  • FirstHealth of the Carolinas-Moore Regional Hospital, Pinehurst, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · jcwilliams@firsthealth.org · 910-715-3500
    Contact: Principal Investigator (Charles S. Kuzma)
  • Duke Cancer Center Raleigh, Raleigh, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · NCTNStudyTeam@dm.duke.edu
    Contact: Principal Investigator (Daniel J. George)
  • AdventHealth Infusion Center Weaverville, Weaverville, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · AMBER.WHEELER@AdventHealth.com · 828-650-8037
    Contact: Principal Investigator (Jennifer L. Heaberlin)
  • Sanford Bismarck Medical Center, Bismarck, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 701-323-5760
    Contact: Principal Investigator (Daniel Almquist)
  • Essentia Health Cancer Center-South University Clinic, Fargo, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Sanford Broadway Medical Center, Fargo, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 701-323-5760
    Contact: Principal Investigator (Daniel Almquist)
  • Sanford Roger Maris Cancer Center, Fargo, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 701-234-6161
    Contact: Principal Investigator (Daniel Almquist)
  • UH Seidman Cancer Center at UH Avon Health Center, Avon, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · 800-641-2422
    Contact: Principal Investigator (Iris Y. Sheng)
  • UHHS-Chagrin Highlands Medical Center, Beachwood, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · CTUReferral@UHhospitals.org · 800-641-2422
    Contact: Principal Investigator (Iris Y. Sheng)
  • Indu and Raj Soin Medical Center, Beavercreek, Ohio, United States

  • Aultman Health Foundation, Canton, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalReserachDept@aultman.com · 330-363-7274
    Contact: Principal Investigator (Aarthi Rajkumar)
  • Miami Valley Hospital South, Centerville, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Case Western Reserve University, Cleveland, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · CTUReferral@UHhospitals.org · 800-641-2422
    Contact: Principal Investigator (Iris Y. Sheng)
  • Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jamesline@osumc.edu · 800-293-5066
    Contact: Principal Investigator (Eric A. Singer)
  • Miami Valley Hospital, Dayton, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Miami Valley Hospital North, Dayton, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Atrium Medical Center-Middletown Regional Hospital, Franklin, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Miami Valley Cancer Care and Infusion, Greenville, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · 937-569-7515
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Kettering Medical Center, Kettering, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Howard M. Gross)
  • UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · CTUReferral@UHhospitals.org · 800-641-2422
    Contact: Principal Investigator (Iris Y. Sheng)
  • Upper Valley Medical Center, Troy, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Cancer Centers of Southwest Oklahoma Research, Lawton, Oklahoma, United States

    Contact: Study coordinator (Site Public Contact) · 877-231-4440
    Contact: Principal Investigator (Adanma Anji Ayanambakkam Attanathi)
  • University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Site Public Contact) · ou-clinical-trials@ouhsc.edu · 405-271-8777
    Contact: Principal Investigator (Adanma Anji Ayanambakkam Attanathi)
  • Providence Newberg Medical Center, Newberg, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Alison K. Conlin)
  • Providence Willamette Falls Medical Center, Oregon City, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Alison K. Conlin)
  • Providence Portland Medical Center, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Alison K. Conlin)
  • Providence Saint Vincent Medical Center, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Alison K. Conlin)
  • Oregon Health and Science University, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · trials@ohsu.edu · 503-494-1080
    Contact: Principal Investigator (Christopher W. Ryan)
  • Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · Morgan_M.Horton@lvhn.org · 610-402-9543
    Contact: Principal Investigator (Houssam Y. Hariri)
  • UPMC-Heritage Valley Health System Beaver, Beaver, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · haneydl@upmc.edu · 412-389-5208
    Contact: Principal Investigator (Leonard J. Appleman)
  • Lehigh Valley Hospital - Muhlenberg, Bethlehem, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · Morgan_M.Horton@lvhn.org · 610-402-9543
    Contact: Principal Investigator (Houssam Y. Hariri)
  • UPMC Hillman Cancer Center at Butler Health System, Butler, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · haneydl@upmc.edu · 412-389-5208
    Contact: Principal Investigator (Leonard J. Appleman)
  • Geisinger Medical Center, Danville, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · HemonCCTrials@geisinger.edu · 570-271-5251
    Contact: Principal Investigator (Sorab Gupta)
  • Geisinger Cancer Center Dickson City, Dickson City, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · hemoncctrials@geisinger.edu · 877-204-6081
    Contact: Principal Investigator (Sorab Gupta)
  • Pocono Medical Center, East Stroudsburg, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · Morgan_M.Horton@lvhn.org · 610-402-9543
    Contact: Principal Investigator (Houssam Y. Hariri)
  • UPMC Hillman Cancer Center Erie, Erie, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalResearchServices@upmc.edu · 412-864-7716
    Contact: Principal Investigator (Leonard J. Appleman)
  • UPMC Cancer Centers - Arnold Palmer Pavilion, Greensburg, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 724-838-1900
    Contact: Principal Investigator (Leonard J. Appleman)
  • UPMC Pinnacle Cancer Center/Community Osteopathic Campus, Harrisburg, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · klitchfield@PINNACLEHEALTH.org · 717-724-6765
    Contact: Principal Investigator (Leonard J. Appleman)
  • Geisinger Medical Center-Cancer Center Hazleton, Hazleton, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · HemonCCTrials@geisinger.edu · 570-459-2901
    Contact: Principal Investigator (Sorab Gupta)
  • Lehigh Valley Hospital-Hazleton, Hazleton, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · Morgan_M.Horton@lvhn.org · 610-402-9543
    Contact: Principal Investigator (Houssam Y. Hariri)
  • UPMC-Johnstown/John P. Murtha Regional Cancer Center, Johnstown, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 814-534-4724
    Contact: Principal Investigator (Leonard J. Appleman)
  • Geisinger Medical Oncology-Lewisburg, Lewisburg, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · HemonCCTrials@geisinger.edu · 570-374-8555
    Contact: Principal Investigator (Sorab Gupta)
  • UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion, Mechanicsburg, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · haneydl@upmc.edu · 412-389-5208
    Contact: Principal Investigator (Leonard J. Appleman)
  • UPMC Hillman Cancer Center - Monroeville, Monroeville, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalResearchServices@upmc.edu · 412-864-7716
    Contact: Principal Investigator (Leonard J. Appleman)
  • Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ONCTrialNow@jefferson.edu · 215-600-9151
    Contact: Principal Investigator (Patrick Mille)
  • Jefferson Torresdale Hospital, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ONCTrialNow@jefferson.edu · 215-600-9151
    Contact: Principal Investigator (Patrick Mille)
  • University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-647-8073
    Contact: Principal Investigator (Leonard J. Appleman)
  • UPMC-Passavant Hospital, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-367-6454
    Contact: Principal Investigator (Leonard J. Appleman)
  • UPMC-Saint Clair Hospital Cancer Center, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-502-3920
    Contact: Principal Investigator (Leonard J. Appleman)
  • Community Medical Center, Scranton, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · HemonCCTrials@geisinger.edu · 570-703-4768
    Contact: Principal Investigator (Sorab Gupta)
  • UPMC Cancer Center-Uniontown, Uniontown, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · protocols@AllianceNCTN.org · 773-702-9171
    Contact: Principal Investigator (Leonard J. Appleman)
  • Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · HemonCCTrials@geisinger.edu · 570-271-5251
    Contact: Principal Investigator (Sorab Gupta)
  • Divine Providence Hospital, Williamsport, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · protocols@AllianceNCTN.org · 773-702-9171
    Contact: Principal Investigator (Leonard J. Appleman)
  • Smilow Cancer Hospital Care Center - Westerly, Westerly, Rhode Island, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (David A. Braun)
  • Prisma Health Cancer Institute - Spartanburg, Boiling Springs, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · Kim.Williams3@prismahealth.org · 864-522-4317
    Contact: Principal Investigator (Ki Y. Chung)
  • Medical University of South Carolina, Charleston, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · hcc-clinical-trials@musc.edu · 843-792-9321
    Contact: Principal Investigator (Thai H. Ho)
  • Prisma Health Cancer Institute - Easley, Easley, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · Kim.Williams3@prismahealth.org · 864-522-4317
    Contact: Principal Investigator (Ki Y. Chung)
  • Gibbs Cancer Center-Gaffney, Gaffney, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · kmertz-rivera@gibbscc.org · 864-560-6104
    Contact: Principal Investigator (Michael Humeniuk)
  • Tidelands Georgetown Memorial Hospital, Georgetown, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · broe@tidelandshealth.org · 843-545-5600
    Contact: Principal Investigator (Thai H. Ho)
  • Prisma Health Cancer Institute - Butternut, Greenville, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · Kim.Williams3@prismahealth.org · 864-522-4317
    Contact: Principal Investigator (Ki Y. Chung)
  • Prisma Health Cancer Institute - Faris, Greenville, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · Kim.Williams3@prismahealth.org · 864-522-4317
    Contact: Principal Investigator (Ki Y. Chung)
  • Prisma Health Cancer Institute - Eastside, Greenville, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · Kim.Williams3@prismahealth.org · 864-522-4317
    Contact: Principal Investigator (Ki Y. Chung)
  • Prisma Health Cancer Institute - Greer, Greer, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · Kim.Williams3@prismahealth.org · 864-522-4317
    Contact: Principal Investigator (Ki Y. Chung)
  • Gibbs Cancer Center-Pelham, Greer, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · kmertz-rivera@gibbscc.org · 864-560-6104
    Contact: Principal Investigator (Michael Humeniuk)
  • Prisma Health Cancer Institute - Seneca, Seneca, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · Kim.Williams3@prismahealth.org · 864-522-4317
    Contact: Principal Investigator (Ki Y. Chung)
  • Spartanburg Medical Center, Spartanburg, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · kmertz-rivera@gibbscc.org · 864-560-6104
    Contact: Principal Investigator (Michael Humeniuk)
  • SMC Center for Hematology Oncology Union, Union, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · kmertz-rivera@gibbscc.org · 864-560-6104
    Contact: Principal Investigator (Michael Humeniuk)
  • Sanford Cancer Center Oncology Clinic, Sioux Falls, South Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicTrialsSF@sanfordhealth.org · 605-312-3320
    Contact: Principal Investigator (Daniel Almquist)
  • Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsSF@SanfordHealth.org · 605-312-3320
    Contact: Principal Investigator (Daniel Almquist)
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville, Tennessee, United States

    Contact: Study coordinator (Site Public Contact) · BCCclintrials@bmhcc.org · 901-226-1366
    Contact: Principal Investigator (Osarenren Ogbeide)
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis, Tennessee, United States

    Contact: Study coordinator (Site Public Contact) · BCCclintrials@bmhcc.org · 901-226-1366
    Contact: Principal Investigator (Osarenren Ogbeide)
  • Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States

    Contact: Study coordinator (Site Public Contact) · 800-811-8480
    Contact: Principal Investigator (Brian I. Rini)
  • The Don and Sybil Harrington Cancer Center, Amarillo, Texas, United States

    Contact: Study coordinator (Site Public Contact) · Gina.Cravey@bsahs.org · 806-212-1985
    Contact: Principal Investigator (Anita Ravipati)
  • Houston Methodist San Jacinto Hospital, Baytown, Texas, United States

    Contact: Study coordinator (Site Public Contact) · protocols@AllianceNCTN.org · 773-702-9171
    Contact: Principal Investigator (Patrick E. Prath)
  • Houston Methodist Cypress Hospital, Cypress, Texas, United States

    Contact: Study coordinator (Site Public Contact) · irb@houstonmethodist.org · 346-356-1413
    Contact: Principal Investigator (Patrick E. Prath)
  • Parkland Memorial Hospital, Dallas, Texas, United States

    Contact: Study coordinator (Site Public Contact) · canceranswerline@UTSouthwestern.edu · 214-590-5582
    Contact: Principal Investigator (Qian Qin)
  • UT Southwestern Simmons Cancer Center - RedBird, Dallas, Texas, United States

    Contact: Study coordinator (Site Public Contact) · canceranswerline@utsouthwestern.edu · 214-648-7097
    Contact: Principal Investigator (Qian Qin)
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States

    Contact: Study coordinator (Site Public Contact) · canceranswerline@UTSouthwestern.edu · 214-648-7097
    Contact: Principal Investigator (Qian Qin)
  • UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth, Texas, United States

    Contact: Study coordinator (Site Public Contact) · canceranswerline@UTSouthwestern.edu · 214-648-7097
    Contact: Principal Investigator (Qian Qin)
  • Houston Methodist Hospital, Houston, Texas, United States

    Contact: Study coordinator (Site Public Contact) · 713-790-2700
    Contact: Principal Investigator (Patrick E. Prath)
  • Methodist Willowbrook Hospital, Houston, Texas, United States

    Contact: Study coordinator (Site Public Contact) · protocols@AllianceNCTN.org · 773-702-9171
    Contact: Principal Investigator (Patrick E. Prath)
  • Houston Methodist West Hospital, Houston, Texas, United States

    Contact: Study coordinator (Site Public Contact) · 832-522-2873
    Contact: Principal Investigator (Patrick E. Prath)
  • Houston Methodist Saint John Hospital, Nassau Bay, Texas, United States

    Contact: Study coordinator (Site Public Contact) · protocols@AllianceNCTN.org · 773-702-9171
    Contact: Principal Investigator (Patrick E. Prath)
  • UT Southwestern Clinical Center at Richardson/Plano, Richardson, Texas, United States

    Contact: Study coordinator (Site Public Contact) · Suzanne.cole@utsouthwestern.edu · 972-669-7044
    Contact: Principal Investigator (Qian Qin)
  • Houston Methodist Sugar Land Hospital, Sugar Land, Texas, United States

    Contact: Study coordinator (Site Public Contact) · 281-242-2873
    Contact: Principal Investigator (Patrick E. Prath)
  • Scott and White Memorial Hospital, Temple, Texas, United States

    Contact: Study coordinator (Site Public Contact) · 254-724-5407
    Contact: Principal Investigator (Lucas Wong)
  • Houston Methodist The Woodlands Hospital, The Woodlands, Texas, United States

    Contact: Study coordinator (Site Public Contact) · hmthewoodlands@houstonmethodist.org · 713-790-2700
    Contact: Principal Investigator (Patrick E. Prath)
  • Central Vermont Medical Center/National Life Cancer Treatment, Berlin Corners, Vermont, United States

    Contact: Study coordinator (Site Public Contact) · 802-225-5400
    Contact: Principal Investigator (Rahul Anil)
  • University of Vermont Medical Center, Burlington, Vermont, United States

    Contact: Study coordinator (Site Public Contact) · rpo@uvm.edu · 802-656-4101
    Contact: Principal Investigator (Rahul Anil)
  • University of Vermont and State Agricultural College, Burlington, Vermont, United States

    Contact: Study coordinator (Site Public Contact) · rpo@uvm.edu · 802-656-8990
    Contact: Principal Investigator (Rahul Anil)
  • Dartmouth Cancer Center - North, Saint Johnsbury, Vermont, United States

  • Bon Secours Memorial Regional Medical Center, Mechanicsville, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · anne_carmellat@bshsi.org · 804-893-8978
    Contact: Principal Investigator (Joseph D. Pennington)
  • Bon Secours Saint Francis Medical Center, Midlothian, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · anne_carmellat@bshsi.org · 804-893-8978
    Contact: Principal Investigator (Joseph D. Pennington)
  • Bon Secours Richmond Community Hospital, Richmond, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · anne_carmellat@bshsi.org · 804-893-8978
    Contact: Principal Investigator (Joseph D. Pennington)
  • Bon Secours Saint Mary's Hospital, Richmond, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · anne_carmellat@bshsi.org · 804-893-8978
    Contact: Principal Investigator (Joseph D. Pennington)
  • Virginia Cancer Institute, Richmond, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · smoore@vacancer.com · 804-287-3000
    Contact: Principal Investigator (Asit K. Paul)
  • VCU Massey Cancer Center at Stony Point, Richmond, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · ctoclinops@vcu.edu
    Contact: Principal Investigator (Asit K. Paul)
  • VCU Massey Comprehensive Cancer Center, Richmond, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · CTOclinops@vcu.edu · 804-628-6430
    Contact: Principal Investigator (Asit K. Paul)
  • VCU Community Memorial Health Center, South Hill, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · nemer.elmouallem@vcuhealth.org
    Contact: Principal Investigator (Asit K. Paul)
  • United Hospital Center, Bridgeport, West Virginia, United States

    Contact: Study coordinator (Site Public Contact) · cancertrialsinfo@hsc.wvu.edu · 304-293-7374
    Contact: Principal Investigator (Joanna A. Kolodney)
  • West Virginia University Charleston Division, Charleston, West Virginia, United States

    Contact: Study coordinator (Site Public Contact) · 304-388-9944
    Contact: Principal Investigator (Kok Hoe Chan)
  • WVUH-Berkely Medical Center, Martinsburg, West Virginia, United States

    Contact: Study coordinator (Site Public Contact) · cancertrialsinfo@hsc.wvu.edu · 304-293-7374
    Contact: Principal Investigator (Joanna A. Kolodney)
  • West Virginia University Healthcare, Morgantown, West Virginia, United States

    Contact: Study coordinator (Site Public Contact) · cancertrialsinfo@hsc.wvu.edu · 304-293-7374
    Contact: Principal Investigator (Joanna A. Kolodney)
  • Camden Clark Medical Center, Parkersburg, West Virginia, United States

    Contact: Study coordinator (Site Public Contact) · cancertrialsinfo@hsc.wvu.edu · 304-293-7374
    Contact: Principal Investigator (Joanna A. Kolodney)
  • ThedaCare Regional Cancer Center, Appleton, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ResearchDept@thedacare.org · 920-364-3604
    Contact: Principal Investigator (Joyce Philip)
  • Duluth Clinic Ashland, Ashland, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Aurora Cancer Care-Southern Lakes VLCC, Burlington, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Adam P. Siegel)
  • Aurora Saint Luke's South Shore, Cudahy, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Adam P. Siegel)
  • Aurora Health Care Germantown Health Center, Germantown, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Adam P. Siegel)
  • Aurora Cancer Care-Grafton, Grafton, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Adam P. Siegel)
  • Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · WI_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Anthony J. Jaslowski)
  • Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · wi_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Anthony J. Jaslowski)
  • Aurora BayCare Medical Center, Green Bay, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Adam P. Siegel)
  • Aurora Cancer Care-Kenosha South, Kenosha, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Adam P. Siegel)
  • Gundersen Lutheran Medical Center, La Crosse, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · cancerctr@gundersenhealth.org · 608-775-2385
    Contact: Principal Investigator (Michael O. Ojelabi)
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · clinicaltrials@cancer.wisc.edu · 800-622-8922
    Contact: Principal Investigator (Hamid Emamekhoo)
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · clinicaltrials@cancer.wisc.edu · 800-622-8922
    Contact: Principal Investigator (Hamid Emamekhoo)
  • Aurora Bay Area Medical Group-Marinette, Marinette, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Adam P. Siegel)
  • Froedtert Menomonee Falls Hospital, Menomonee Falls, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 262-257-5100
    Contact: Principal Investigator (Kathryn A. Bylow)
  • Aurora Cancer Care-Milwaukee, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Adam P. Siegel)
  • Aurora Saint Luke's Medical Center, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Adam P. Siegel)
  • Medical College of Wisconsin, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 414-805-3666
    Contact: Principal Investigator (Kathryn A. Bylow)
  • Aurora Sinai Medical Center, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Adam P. Siegel)
  • ProHealth D N Greenwald Center, Mukwonago, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · research.institute@phci.org
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • Cancer Center of Western Wisconsin, New Richmond, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Drexel Town Square Health Center, Oak Creek, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 414-805-0505
    Contact: Principal Investigator (Kathryn A. Bylow)
  • ProHealth Oconomowoc Memorial Hospital, Oconomowoc, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 262-928-7878
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • Saint Vincent Hospital Cancer Center at Oconto Falls, Oconto Falls, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · WI_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Anthony J. Jaslowski)
  • Vince Lombardi Cancer Clinic - Oshkosh, Oshkosh, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Adam P. Siegel)
  • Aurora Cancer Care-Racine, Racine, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Adam P. Siegel)
  • Saint Vincent Hospital Cancer Center at Sheboygan, Sheboygan, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · wi_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Anthony J. Jaslowski)
  • Sheboygan Physicians Group, Sheboygan, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · wi_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Anthony J. Jaslowski)
  • Vince Lombardi Cancer Clinic-Sheboygan, Sheboygan, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Adam P. Siegel)
  • Saint Vincent Hospital Cancer Center at Sturgeon Bay, Sturgeon Bay, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · wi_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Anthony J. Jaslowski)
  • Aurora Medical Center in Summit, Summit, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Adam P. Siegel)
  • Vince Lombardi Cancer Clinic-Two Rivers, Two Rivers, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Adam P. Siegel)
  • ProHealth Waukesha Memorial Hospital, Waukesha, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 262-928-7632
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • UW Cancer Center at ProHealth Care, Waukesha, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · Chanda.miller@phci.org · 262-928-5539
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • Aurora Cancer Care-Milwaukee West, Wauwatosa, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Adam P. Siegel)
  • Aurora West Allis Medical Center, West Allis, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Adam P. Siegel)
  • Froedtert West Bend Hospital/Kraemer Cancer Center, West Bend, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 414-805-0505
    Contact: Principal Investigator (Kathryn A. Bylow)